Does the Wearable Cardioverter Defibrillator (WCD) safely protect high-risk cardiac patients not eligible for an implantable cardioverter defibrillator from sustained ventricular tachyarrhythmias?
The WEARIT-II Registry suggests the wearable cardioverter defibrillator is safe and detects a high rate of ventricular tachyarrhythmias in high-risk patients awaiting ICD eligibility.
The WEARIT-II Registry demonstrates a high rate of sustained ventricular tachyarrhythmias at 3 months in at-risk patients who are not eligible for an implantable cardioverter defibrillator, and suggests that the WCD can be safely used to protect patients during this period of risk assessment.
Kutyifa et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: